financetom
Business
financetom
/
Business
/
Tapestry raises annual earnings target on robust Tabby handbags demand
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Tapestry raises annual earnings target on robust Tabby handbags demand
Nov 9, 2024 12:02 PM

(Reuters) -Tapestry raised its annual earnings forecast and surpassed first-quarter estimates on Thursday, as the Coach parent benefited from full-prices sales of its popular Tabby handbags and sending its shares up 5% before the bell.

Shoppers, particularly in the middle- and upper-middle income category, have splurged on trendy apparel and accessories even as they pared back on most non-essential purchases in the face of sticky inflation this year.

Tapestry's Tabby bags, which sell for as much as $750, have been a customer favorite for several years, garnering appeal among younger customers.

Sales at Coach, which houses Tabby and accounts for more than a third of Tapestry's total revenue, rose 2% in constant currency.

Robust demand in Europe, indicated from a 27% jump in sales during the quarter, also helped the company weather a 5% drop in revenue in its key market of Greater China.

In contrast, European luxury giant LVMH missed its quarterly sales expectations in October, hurt by weak demand in key markets of China and Japan as consumer confidence weakened.

Tapestry, whose pending $8.5 billion merger with Michael Kors parent Capri was blocked by a U.S. judge last month, now expects its 2025 earnings per share to be between $4.50 and $4.55, compared with the $4.45 to $4.50 forecast earlier.

Tight cost control and more full-price sales have also helped the company's gross margins expand for eight straight quarters. They were up 280 basis points in the three months ended Sept. 28.

Tapestry's first-quarter revenue of $1.51 billion beat analysts' estimate of $1.47 billion, according to data compiled by LSEG. Its adjusted earnings per share of $1.02 also topped expectations.

The company had said earlier it plans to appeal against U.S. District Judge Jennifer Rochon's decision to block its merger with peer Capri.

Separately, in the day, pricey parkas maker Canada Goose also beat revenue expectations. Capri is scheduled to report its second-quarter results after markets close.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Kitchen sponge maker Scrub Daddy explores sale, sources say
Kitchen sponge maker Scrub Daddy explores sale, sources say
Mar 28, 2024
March 28 (Reuters) - Scrub Daddy, the kitchen sponge maker that gained popularity after securing an investment on U.S. TV show Shark Tank, is exploring options that include a sale of the company, according to people familiar with the matter. Scrub Daddy, which is backed by entrepreneur Lori Greiner, has hired JPMorgan Chase ( JPM ) to advise on whether...
Market Chatter: Nutrien Considers Divestments, Management Changes in South American Operations
Market Chatter: Nutrien Considers Divestments, Management Changes in South American Operations
Mar 28, 2024
02:33 PM EDT, 03/28/2024 (MT Newswires) -- Nutrien ( NTR ) is considering strategic changes in South America over significant losses in the region including divestments, new management and stopping its acquisition spree in Brazil, Reuters reported Thursday, citing sources with direct knowledge of the matter. The company has already separated Brazil from the rest of its regional operations and...
CANADA ECONOMICS FEATURE: CIBC's Avery Shenfeld On the Productivity Malaise
CANADA ECONOMICS FEATURE: CIBC's Avery Shenfeld On the Productivity Malaise
Mar 28, 2024
02:33 PM EDT, 03/28/2024 (MT Newswires) -- Avery Shenfeld noted Thursday this week's speech by the Bank of Canada's Carolyn Rogers drew useful attention to the symptoms of Canada's productivity malaise. But, he said, we're still left without much progress towards a diagnosis, the first step towards a cure, and that might explain why public policy efforts in this area...
4D Molecular Reports Regulatory Updates on 4D-710 For Cystic Fibrosis
4D Molecular Reports Regulatory Updates on 4D-710 For Cystic Fibrosis
Mar 28, 2024
02:32 PM EDT, 03/28/2024 (MT Newswires) -- 4D Molecular Therapeutics ( FDMT ) said it conducted initial pivotal study interactions with the US Food and Drug Administration and European Medicines Agency over its development plans for 4D-710 for treatment of cystic fibrosis lung disease. We are encouraged by our productive interactions with the FDA and EMA, said CEO David Kirn....
Copyright 2023-2025 - www.financetom.com All Rights Reserved